BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26519943)

  • 1. Increased expression and dysregulated association of restriction factors and type I interferon in HIV, HCV mono- and co-infected patients.
    Zhu JW; Liu FL; Mu D; Deng DY; Zheng YT
    J Med Virol; 2016 Jun; 88(6):987-95. PubMed ID: 26519943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients.
    Medrano LM; Rallón N; Berenguer J; Jiménez-Sousa MA; Soriano V; Aldámiz-Echevarria T; Fernández-Rodríguez A; García M; Tejerina F; Martínez I; Benito JM; Resino S
    J Transl Med; 2016 Sep; 14(1):257. PubMed ID: 27590274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Key Elements in the Innate Immunity System Among Patients with HIV, HCV, and Coinfections of HIV/HCV.
    Moradi M; Tabibzadeh A; Javanmard D; Ghorbani S; Bokharaei-Salim F; Keivani H; Khazeni M; Monavari SHR
    Curr HIV Res; 2020; 18(3):194-200. PubMed ID: 32209045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heroin use is associated with lower levels of restriction factors and type I interferon expression and facilitates HIV-1 replication.
    Zhu JW; Liu FL; Mu D; Deng DY; Zheng YT
    Microbes Infect; 2017; 19(4-5):288-294. PubMed ID: 28104465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment.
    Singh R; Patel V; Mureithi MW; Naranbhai V; Ramsuran D; Tulsi S; Hiramen K; Werner L; Mlisana K; Altfeld M; Luban J; Kasprowicz V; Dheda K; Abdool Karim SS; Ndung'u T
    J Virol; 2014 Apr; 88(8):4291-303. PubMed ID: 24478420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection.
    Singh R; Gaiha G; Werner L; McKim K; Mlisana K; Luban J; Walker BD; Karim SS; Brass AL; Ndung'u T;
    J Virol; 2011 Jan; 85(1):208-16. PubMed ID: 20980524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.
    Papasavvas E; Azzoni L; Yin X; Liu Q; Joseph J; Mackiewicz A; Ross B; Lynn KM; Jacobson JM; Mounzer K; Kostman JR; Montaner LJ
    J Viral Hepat; 2017 Oct; 24(10):865-876. PubMed ID: 28419653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A.
    Yang C; Zhao X; Sun D; Yang L; Chong C; Pan Y; Chi X; Gao Y; Wang M; Shi X; Sun H; Lv J; Gao Y; Zhong J; Niu J; Sun B
    Cell Mol Immunol; 2016 Jan; 13(1):94-102. PubMed ID: 25683609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide mRNA and miRNA analysis of peripheral blood mononuclear cells (PBMC) reveals different miRNAs regulating HIV/HCV co-infection.
    Gupta P; Liu B; Wu JQ; Soriano V; Vispo E; Carroll AP; Goldie BJ; Cairns MJ; Saksena NK
    Virology; 2014 Feb; 450-451():336-49. PubMed ID: 24503097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An investigation of clinical features and immunological functions of HCV-specific cytotoxic T lymphocytes in HIV/HCV co-infected patients].
    DU XF; Zhang YH; Ma LN; Yan HP; Chen XY; Wu H
    Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):345-8. PubMed ID: 18510845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients.
    Sticchi L; Di Biagio A; Sartini M; Rappazzo E; Nicolini LA; Cenderello G; Valle C; Azzola E; Grasso A; De Leo P; Boldrini A; Setti M; Prinapori R; Lorusso C; Bruzzone B; Icardi G;
    New Microbiol; 2015 Oct; 38(4):499-509. PubMed ID: 26485009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differential response to pegylated interferon plus ribavirin combination therapy in chronic hepatitis C and HIV/HCV co-infected patients].
    Liu B; Cai WP; Hu FY; Xu M; Lan Y; Tang XP
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):829-33. PubMed ID: 24331692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirin.
    Jabłonowska E; Piekarska A; Koślińska-Berkan E; Omulecka A; Szymańska B; Wójcik K
    Acta Biochim Pol; 2012; 59(3):333-7. PubMed ID: 22924160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection.
    Whitmill A; Kim S; Rojas V; Gulraiz F; Afreen K; Jain M; Singh M; Park IW
    PLoS One; 2018; 13(8):e0202524. PubMed ID: 30138348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible Human Immunodeficiency Virus Type-1 Latency in Primary Human Monocyte-Derived Macrophages Induced by Sustained M1 Polarization.
    Graziano F; Aimola G; Forlani G; Turrini F; Accolla RS; Vicenzi E; Poli G
    Sci Rep; 2018 Sep; 8(1):14249. PubMed ID: 30250078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA expression profiles in liver grafts of HCV and HIV/HCV-infected recipients, 6 months after liver transplantation.
    Bulfoni M; Pravisani R; Dalla E; Cesselli D; Hidaka M; Di Loreto C; Eguchi S; Baccarani U
    J Med Virol; 2021 Aug; 93(8):4992-5000. PubMed ID: 33818800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-27 is differentially associated with HIV viral load and CD4+ T cell counts in therapy-naïve HIV-mono-infected and HIV/HCV-co-infected Chinese.
    He L; Zhao J; Wang MH; Siu KK; Gan YX; Chen L; Zee BC; Yang L; Kung HF; Yang ZR; He ML
    PLoS One; 2014; 9(5):e96792. PubMed ID: 24816922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon alpha receptors and STAT1 as therapy predictors of a sustained virological response in hepatitis C/B co-infection.
    Asim M; Rashid A; Khan A
    J Pak Med Assoc; 2018 Nov; 68(11):1446-1450. PubMed ID: 30410131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GNB3 C825T polymorphism affects response to HCV therapy with pegylated interferon in HCV/HIV co-infected but not in HCV mono-infected patients.
    Ahlenstiel G; Nischalke HD; Bueren K; Berg T; Vogel M; Biermer M; Grünhage F; Sauerbruch T; Rockstroh J; Spengler U; Nattermann J
    J Hepatol; 2007 Sep; 47(3):348-55. PubMed ID: 17559964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of hepatitis C virus RNA in peripheral blood mononuclear cells in HCV-monoinfection and HIV/HCV-coinfection.
    Chary A; Winters MA; Eisen R; Knight TH; Asmuth DM; Holodniy M
    J Med Virol; 2012 Mar; 84(3):431-7. PubMed ID: 22246828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.